Hospitalized COVID-19 patients have to be routinely evaluated in relation to the coagulation profile, including D-dimer, thromboplastin, platelets, fibrinogen, and thromboplastin, since they present increased risk to clotting and thrombosis. Here, F3 is linked to COVID-19.